|
|
W J Murphy, L A Welniak, D D Taub, R H Wiltrout, P A Taylor, D A Vallera, M Kopf, H Young, D L Longo, B R Blazar
J Clin Invest. 1998;
102(9):1742
doi:10.1172/JCI3906
Abstract |
Full text
| PDF

G
raft-versus-host disease (GVHD), in which immunocompetent donor cells attack the host, remains a major cause of morbidity after allogeneic bone marrow transplantation (BMT). To understand the role of cytokines in the pathobiology of GVHD, we used cytokine knockout (KO) mice as a source of donor T cells. Two different MHC-disparate strain combinations were examined: BALB/c (H2(d)) donors into lethally irradiated C57BL/6 (H2(b)) recipients or C57BL/6 (H2(b)) donors into B10.BR (H2(k)) recipients. Donor cells were from mice in which either the interferon-gamma (IFN-gamma) or the IL-4 gene was selectively disrupted to understand the role of these cytokines in acute GVHD. In both strain combinations the same pattern was noted with regard to GVHD onset and morbidity. All mice exhibited the classic signs of acute GVHD: weight loss with skin, gut, and liver pathology resulting in morbidity and mortality. Surprisingly, donor cells obtained from mice lacking IFN-gamma gave rise to accelerated morbidity from GVHD when compared with cells from wild-type control donors. Similar results were obtained using normal donors when neutralizing antibodies to IFN-gamma were administered immediately after the BMT. These results suggest that IFN-gamma plays a role in protection from acute GVHD. In marked contrast, cells obtained from IL-4 KO mice resulted in protection from GVHD compared with control donors. Splenocytes from IFN KO mice stimulated with a mitogen proliferated to a significantly greater extent and produced more IL-2 compared with splenocytes obtained from IL-4 KO or control mice. Additionally, there was increased IL-2 production in the spleens of mice undergoing GVHD using IFN-gamma KO donors. These results therefore indicate, with regard to the TH1/ TH2 cytokine paradigm, the absence of a TH1-type cytokine can be deleterious in acute GVHD, whereas absence of a TH2 cytokine can be protective.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(23)
| Title and authors |
Publication |
Year |
The IL-17 Differentiation Pathway and Its Role in Transplant Outcome
Jonathan S. Serody, Geoffrey R. Hill
|
Biology of Blood and Marrow Transplantation
|
2012 |
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
K. L. Hippen, C. Bucher, D. K. Schirm, A. M. Bearl, T. Brender, K. A. Mink, K. S. Waggie, R. Peffault de Latour, A. Janin, J. M. Curtsinger
|
Blood
|
2012 |
Regulatory T cells and IL-17-producing cells in graft-versus-host disease
Takanori Teshima, Yoshinobu Maeda, Katsutoshi Ozaki
|
Immunotherapy
|
2011 |
Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation
L. Lai, C. Cui, J. Jin, Z. Hao, Q. Zheng, M. Ying, R. Boyd, Y. Zhao
|
Blood
|
2011 |
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
J. M. Coghill, S. Sarantopoulos, T. P. Moran, W. J. Murphy, B. R. Blazar, J. S. Serody
|
Blood
|
2011 |
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease
Isao Tawara, Evelyn Nieves, Chen Liu, Rebecca Evers, Tomomi Toubai, Yaping Sun, Mariem Alrubaie, Pavan Reddy
|
Biology of Blood and Marrow Transplantation
|
2011 |
IFN- promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation
Y. Yang, H. Wang, H. Yu, B. Y. Yeap, T. Liang, G. Wang, T. Cheng, Y.-G. Yang
|
Blood
|
2011 |
Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?
Øystein Bruserud, Elisabeth Ersvær, Guro Kristin Melve
|
Cancer Immunol Immunother
|
2011 |
Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR t in mice
Y. Yu, D. Wang, C. Liu, K. Kaosaard, K. Semple, C. Anasetti, X.-Z. Yu
|
Blood
|
2011 |
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease
Y. Zhang, A. R. Sandy, J. Wang, V. Radojcic, G. T. Shan, I. T. Tran, A. Friedman, K. Kato, S. He, S. Cui, E. Hexner, D. M. Frank, S. G. Emerson, W. S. Pear, I. Maillard
|
Blood
|
2010 |
|